Source link : https://www.newshealth.biz/health-news/novel-drug-for-chronic-inducible-urticaria-delivers-in-mid-stage-trial/
BOSTON — Treatment with an investigational anti-KIT monoclonal antibody induced clinically meaningful responses in the two most common forms of chronic inducible urticaria, a dose-ranging phase II trial showed. In patients with inadequately controlled disease despite antihistamines, up to 53% of those with cold urticaria and up to 58% of those with symptomatic dermographism achieved […]
Author : News Health
Publish date : 2024-10-29 21:46:07
Copyright for syndicated content belongs to the linked Source.